110 related articles for article (PubMed ID: 26755075)
21. A dosimetric analysis comparing treatment of low-risk prostate cancer with TomoTherapy versus static field intensity modulated radiation therapy.
Shah AP; Chen SS; Strauss JB; Kirk MC; Coleman JL; Coon AB; Miller C; Dickler A
Am J Clin Oncol; 2009 Oct; 32(5):460-6. PubMed ID: 19564784
[TBL] [Abstract][Full Text] [Related]
22. Optimising the dosimetric quality and efficiency of post-prostatectomy radiotherapy: a planning study comparing the performance of volumetric-modulated arc therapy (VMAT) with an optimised seven-field intensity-modulated radiotherapy (IMRT) technique.
Nguyen BT; Hornby C; Kron T; Cramb J; Rolfo A; Pham D; Haworth A; Tai KH; Foroudi F
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):211-9. PubMed ID: 22498196
[TBL] [Abstract][Full Text] [Related]
23. Pelvic Lymph Node Irradiation Including Pararectal Sentinel Nodes for Prostate Cancer Patients: Treatment Optimization Comparing Intensity Modulated X-rays, Volumetric Modulated Arc Therapy, and Intensity Modulated Proton Therapy.
Vees H; Dipasquale G; Nouet P; Zilli T; Cozzi L; Miralbell R
Technol Cancer Res Treat; 2015 Apr; 14(2):181-9. PubMed ID: 24694113
[TBL] [Abstract][Full Text] [Related]
24. Experience-based quality control of clinical intensity-modulated radiotherapy planning.
Moore KL; Brame RS; Low DA; Mutic S
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):545-51. PubMed ID: 21277097
[TBL] [Abstract][Full Text] [Related]
25. A knowledge-based approach to improving and homogenizing intensity modulated radiation therapy planning quality among treatment centers: an example application to prostate cancer planning.
Good D; Lo J; Lee WR; Wu QJ; Yin FF; Das SK
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):176-81. PubMed ID: 23623460
[TBL] [Abstract][Full Text] [Related]
26. A predictive model for determining rectum and bladder dose constraints in prostate volumetric modulated arc therapy.
Chao M; Coburn N; Cosgriff E; Brown C; Van Tilburg K; Hayden A
Med Dosim; 2021 Autumn; 46(3):269-273. PubMed ID: 33726940
[TBL] [Abstract][Full Text] [Related]
27. Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes.
Yoo S; Wu QJ; Lee WR; Yin FF
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):935-42. PubMed ID: 20044214
[TBL] [Abstract][Full Text] [Related]
28. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
[TBL] [Abstract][Full Text] [Related]
29. Dosimetric effect of photon beam energy on volumetric modulated arc therapy treatment plan quality due to body habitus in advanced prostate cancer.
Stanley DN; Popp T; Ha CS; Swanson GP; Eng TY; Papanikolaou N; Gutiérrez AN
Pract Radiat Oncol; 2015; 5(6):e625-33. PubMed ID: 26419443
[TBL] [Abstract][Full Text] [Related]
30. A quality control model that uses PTV-rectal distances to predict the lowest achievable rectum dose, improves IMRT planning for patients with prostate cancer.
Wang Y; Zolnay A; Incrocci L; Joosten H; McNutt T; Heijmen B; Petit S
Radiother Oncol; 2013 Jun; 107(3):352-7. PubMed ID: 23830193
[TBL] [Abstract][Full Text] [Related]
31. Dosimetric advantages and superior treatment delivery efficiency of RapidArc over conventional intensity-modulated radiotherapy in high-risk prostate cancer involving seminal vesicles and pelvic nodes.
Poon DM; Kam M; Leung CM; Chau R; Wong S; Lee WY; Wong KC; Yu B; Chan A
Clin Oncol (R Coll Radiol); 2013 Dec; 25(12):706-12. PubMed ID: 23954261
[TBL] [Abstract][Full Text] [Related]
32. Volumetric-modulated arc therapy in postprostatectomy radiotherapy patients: a planning comparison study.
Forde E; Kneebone A; Bromley R; Guo L; Hunt P; Eade T
Med Dosim; 2013; 38(3):262-7. PubMed ID: 23623354
[TBL] [Abstract][Full Text] [Related]
33. Dosimetric comparison between Volumetric Modulated Arc Therapy (VMAT) vs Intensity Modulated Radiation Therapy (IMRT) for radiotherapy of mid esophageal carcinoma.
Kataria T; Govardhan HB; Gupta D; Mohanraj U; Bisht SS; Sambasivaselli R; Goyal S; Abhishek A; Srivatsava A; Pushpan L; Kumar V; Vikraman S
J Cancer Res Ther; 2014; 10(4):871-7. PubMed ID: 25579521
[TBL] [Abstract][Full Text] [Related]
34. Influence of organ motion on conformal vs. intensity-modulated pelvic radiotherapy for prostate cancer.
Hysing LB; Skorpen TN; Alber M; Fjellsbø LB; Helle SI; Muren LP
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1496-503. PubMed ID: 18538493
[TBL] [Abstract][Full Text] [Related]
35. Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy, and intensity-modulated radiation therapy for left-sided early breast cancer.
Lin JF; Yeh DC; Yeh HL; Chang CF; Lin JC
Med Dosim; 2015; 40(3):262-7. PubMed ID: 26116150
[TBL] [Abstract][Full Text] [Related]
36. Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases.
Cilla S; Deodato F; Digesù C; Macchia G; Picardi V; Ferro M; Sallustio G; De Spirito M; Piermattei A; Morganti AG
Med Dosim; 2014; 39(1):108-16. PubMed ID: 24342167
[TBL] [Abstract][Full Text] [Related]
37. Dosimetric advantage and clinical implication of a micro-multileaf collimator in the treatment of prostate with intensity-modulated radiotherapy.
Wang L; Hoban P; Paskalev K; Yang J; Li J; Chen L; Xiong W; Ma CC
Med Dosim; 2005; 30(2):97-103. PubMed ID: 15922176
[TBL] [Abstract][Full Text] [Related]
38. Dosimetric and efficiency comparison of high-dose radiotherapy for esophageal cancer: volumetric modulated arc therapy versus fixed-field intensity-modulated radiotherapy.
Lin CY; Huang WY; Jen YM; Chen CM; Su YF; Chao HL; Lin CS
Dis Esophagus; 2014 Aug; 27(6):585-90. PubMed ID: 24134466
[TBL] [Abstract][Full Text] [Related]
39. Investigation of pulsed IMRT and VMAT for re-irradiation treatments: dosimetric and delivery feasibilities.
Lin MH; Price RA; Li J; Kang S; Li J; Ma CM
Phys Med Biol; 2013 Nov; 58(22):8179-96. PubMed ID: 24200917
[TBL] [Abstract][Full Text] [Related]
40. A quantitative study of IMRT delivery effects in commercial planning systems for the case of oesophagus and prostate tumours.
Seco J; Clark CH; Evans PM; Webb S
Br J Radiol; 2006 May; 79(941):401-8. PubMed ID: 16632620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
